Immunovant Inc.
Immunovant is a clinical-stage biopharmaceutical company developing treatments for autoimmune diseases.
Company Location
2530 Meridian Parkway, Suite 3041
Durham
NC
27713
Phone
County
Region
Company Details
Company type
Year founded
2018
Employment range in NC
US headquarters
New York
Global headquarters
United States
Primary site activity
All company activities
Core capabilities
Potential end market(s)
Products under development
IMVT-1401, a novel, fully homan monoclonal antibody targeting the neonatal Fc receptor. Current indications being investigated are myasthenia gravis (MG), Graves' ophthalmopathy (GO), and Warm Autoimmune Hemolytic Anemia (WAIHA)